![](https://webarchive.library.unt.edu/web/20121008024403im_/http://www.pfizer.com/img/1x1.gif)
- Argentina
- Finland
- Japan
- Senegal
- France
- Korea
- Slovakia
- Australia
- Germany
- Malaysia/Singapore
- South Africa
- Austria
- Greece
- Mexico
- Spain
- Belgium
- Hong Kong
- Netherlands
- Sweden
- Brazil
- Hungary
- New Zealand
- Switzerland
- Canada
- India
- Norway
- Taiwan
- China
- Indonesia
- Pakistan
- Thailand
- Colombia
- Ireland
- Philippines
- Turkey
- Czech Republic
- Israel
- Poland
- United Kingdom
- Denmark
- Italy
- Portugal
- Venezuela
October 04, 2012
— Pfizer Announces Top-Line Results Of Prevenar 13® Phase 3 Trial In Adults 18 To 49 Years Of Age
http://pfizer.newshq.businesswire.com/press-release/pfizer-announces-top-line-results-prevenar-13-phase-3-trial-adults-18-49-years-age
October 04, 2012
— Pfizer Announces Data For Investigational Compound Tofacitinib In Rheumatoid Arthritis To Be Presented At The American College Of Rheumatology 2012 Annual Meeting
http://pfizer.newshq.businesswire.com/press-release/pfizer-announces-data-investigational-compound-tofacitinib-rheumatoid-arthritis-be-pre
http://pfizer.newshq.businesswire.com/press-release/fda-acknowledges-receipt-resubmission-eliquis-apixaban-new-drug-application-reduce-ris
Looking for Wyeth.com?
Investor Presentations
Pfizer Quarterly Corporate Performance – Third Quarter 2012
- Audio Webcast – Tuesday, October 30, 2012 – 10 AM E.D.T.
- Read press release issued September 21, 2012
UBS Global Life Sciences Conference
- Audio Webcast – Thursday, September 20, 2012 – 9:00 AM E.D.T.
- Download Presentation (6.85 MB) PDF
- Download Transcript (127 KB) PDF
Morgan Stanley Global Healthcare Conference
- Audio Webcast – Tuesday, September 11, 2012 – 9:10 AM E.D.T.
- Download Transcript (156 KB) PDF